C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 259/06 (2006.01) A61K 31/34 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 31/415 (2006.01) A61K 31/425 (2006.01) A61K 31/44 (2006.01) A61K 31/495 (2006.01) C07C 233/31 (2006.01) C07D 207/32 (2006.01) C07D 209/46 (2006.01) C07D 209/48 (2006.01) C07D 233/34 (2006.01) C07D 233/72 (2006.01) C07D 307/46 (2006.01) C07D 307/52 (2006.01) C07D 309/12 (2006.01) C07D 333/40 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01) C07D 407/12 (2006.01) C07D 409/1
Patent
CA 2332946
Hydroxamic acid derivatives represented by general formula (I) or pharmacologically acceptable salts thereof; medicinal compositions containing the same and medicinal utilization thereof wherein each symbol has the meaning as defined in the specification. Because of having TNF-.alpha. production inhibitory effect, these derivatives or pharmacologically acceptable salts thereof are useful in preventing/treating autoimmune diseases and inflammatory diseases, for example, sepsis, MOF, rheumatoid arthritis, Crohn's disease, cachexia, myasthenia gravis, systemic lupus erythematosus, asthma, I type diabetes and psoriasis.
L'invention se rapporte à des dérivés d'acide hydroxamique représentés par la formule générale (I), à des sels pharmacologiquement acceptables de ces dérivés, à des compositions médicinales contenant de tels dérivés et à leur utilisation médicinale. Dans la formule (I), chaque symbole a la signification spécifiée dans la description de l'invention. En raison de leur effet inhibiteur vis à vis de la production de TNF-.alpha., ces dérivés ou leurs sels pharmacologiquement acceptables s'avèrent utiles pour prévenir/traiter les maladies auto-immunes et les maladies inflammatoires du type septicémie, MOF, polyarthrite rhumatoïde, maladie de Crohn, cachexie, myasthénie grave, lupus érythémateux disséminé, asthme, diabète insulino-dépendant et psoriasis.
Gotou Tomokazu
Maeda Kazuhiro
Sugiyama Naoki
Takeda Shinji
Takemoto Tadahiro
Fetherstonhaugh & Co.
Mitsubishi Pharma Corporation
Welfide Corporation
LandOfFree
Hydroxamic acid derivative and pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid derivative and pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid derivative and pharmaceutical use thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1906881